Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | Y011267 | — |
No symptoms reported as of now; inadvertently administered an extra dose of the PEDVAXHIB Vaccine. This patient was already fully vaccinated; Patient 11 years old; This spontaneous report was received from a nurse and refers to a(n) 11-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-May-2025, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), (lot #Y011267, expiration date: 08-Nov-2026) as prophylaxis. On 07-May-2025, the patient experienced inadvertently administered an extra dose of the PEDVAXHIB Vaccine (Extra dose administered). This patient was already fully vaccinated . The patient was 11 years old (Product administered to patient of inappropriate age). No symptoms reported as of now (No adverse event). At the reporting time, the outcome of the events was reported as unknown. The action taken with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) was reported as not applicable.